New Information on Statins and Cardiovascular Risk – Asrar Qureshi’s Blog Post #1169

Asrar Qureshi’s blog post discusses new cardiovascular risk estimation equations released by the American Heart Association, known as PREVENT. These models show lower risk estimates than previous Pooled Cohort Equations, resulting in fewer patients qualifying for statin therapy. The changes aim to improve precision, reduce overtreatment, and promote equity in cardiovascular care.
Share
View Post

Expected Changes for Contract Research Organizations – Asrar Qureshi’s Blog Post #1040

This blog post by Asrar Qureshi discusses the role of Contract Research Organizations (CROs) in pharmaceutical development, including their services like clinical trial management and regulatory support. It highlights challenges and evolving trends in the industry, such as technology integration and changing sponsor needs, emphasizing the importance of adaptation for CROs’ future success.
Share